Strategic Licensing Agreements: Brii Bio’s Expansion into Chronic Disease Treatments with VBI Vaccines
By Daniella Parra Brii Biosciences and VBI Vaccines (NASDAQ: VBIV) said they will expand and...
By Daniella Parra Brii Biosciences and VBI Vaccines (NASDAQ: VBIV) said they will expand and...
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
By Carola McGiffert The U.S. government through successive administrations has sought to keep China from...
By Daniella Parra Agendia said it has enrolled the first patient using MammaPrint for the...
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it’s with the University of Florida’s Center...
Tech Edge and the Palm Beach Hedge Fund Association will host a fireside chat...
By Exec Edge Editorial Staff Thank you both for joining me today. Let’s start with...
By Karen E. Roman Sirnaomics Ltd., a biopharmaceutical company developing RNAi therapeutics, recently published a...
By Daniella Parra Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) said it showed additional safety and...
Exec Edge hosted a fireside chat at the 2024 ICR Conference with TRAY’s CEO and Founder Peter...